Ardelyx, Inc. (ARDX) vs Corvus Pharmaceuticals, Inc. (CRVS)
- Ardelyx, Inc. ARDX 3.09 −5.50%
- Corvus Pharmaceuticals, Inc. CRVS 9.52 −3.35%
Ardelyx, Inc. and Corvus Pharmaceuticals, Inc. are both Biotechnology companies. Ardelyx, Inc. and Corvus Pharmaceuticals, Inc. are of similar size ($828.6M and $814.9M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −12.4%) and the lower return on invested capital (−352.5% vs −18.6%). Across the 14 metrics below, Corvus Pharmaceuticals, Inc. leads on 10 and Ardelyx, Inc. on 4.
Valuation
Profitability
| Metric | ARDX | CRVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 0.00% | 65.16% |
| Operating margin | (7.86%) | 0.00% | 0.00% |
| Net margin | (12.35%) | 0.00% | 0.00% |
| Free cash flow margin | (3.97%) | 0.00% | 0.00% |
| Return on equity | (38.61%) | (18.98%) | (56.36%) |
| Return on assets | (10.68%) | (17.64%) | (48.04%) |
| Return on invested capital | (18.62%) | (352.49%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack